Usually only a single dose of antibiotics is prescribed to treat gonorrhea, such as:
For infected pregnant women or young people up to 18 years old, it is not recommended to use ciprofloxacin or Ofloxacin. The choice remains the doctor’s, who can prescribe the best and safest option for a specific case. Gonococcal infection is usually accompanied by other sexually transmitted diseases. Therefore, doctors prescribe a combination of antibiotics, such as ceftriaxone and doxycycline or azithromycin, which will treat both diseases at the same time. Complications that can occur in the absence of treatment: In the event the disease remains untreated, the bacteria will spread to the entire genital tract, or in some of the cases, it, through blood dissemination, can affect the joints, the heart’s valve system or the central nervous system. The most common result of untreated gonorrhea is pelvic inflammatory disease (PID), a serious infection of the female reproductive organs. Gonococcal PID often appears immediately after the end of the menstrual period. IP can cause scarring in the fallopian tubes. If the tube is partially scarred, the fertilized egg cannot reach the uterus. If this happens, the embryo may implant in the tube causing an extra uterine pregnancy. This serious complication can cause a miscarriage and can lead to maternal death. For those affected by gonococcal infection, they have an increased risk of HIV infection, so it is important to prevent or treat it in the early stages of the disease.
Gonorrhea and infants:
Pregnant women infected with gonorrhea can transmit the infection during childbirth. The doctor can prevent the eye infection by administering silver nitrate or other medications immediately after birth. Due to the high risk of infection, pregnant women are recommended at least one gonorrhea testing during pregnancy.
Prevention of gonorrhea:
To reduce the risk of gonococcal infection it is necessary to use condoms correctly during normal or anal sexual acts.
Researchers supported by the National Institute of Allergy and Infectious Diseases (NIAID) continue to study the bacteria that causes gonorrhea and are working on better methods of prevention, diagnosis and treatment of this disease. A very important issue puts the emergence of drug-resistant gonococcal bacteria, which highlights the need for more effective methods of prevention, such as a vaccine. So far they have developed techniques for detecting drug-resistant bacteria groups, techniques to help physicians in choosing appropriate treatment, but a general vaccine has yet to be produced. Soon, gonorrhea will be a disease that will no longer be treated as it already has become resistant to many types of treatment, according to the World Health Organization warnings. Every year, more than 106 million new cases appear, demonstrated by statistics institutions. A report published last year shows that in Japan, in 2008, the disease could not be treated with any antibiotic used previously, informs Reuters, quoted by International Business Times. “If it was a local phenomenon, not too many years will pass before it becomes a global one!” cautions Dr. Manjula Lusti-Narasimhan, of the WHO. Already fears have come true in countries such as Australia, France, Norway, Sweden and the UK, as some sexually transmitted disease can no longer be treated with current antibiotic classes.